← All trials
NCT05394740
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 6, 2022
- Primary completion
- May 31, 2024
- Completion date
- Nov 30, 2025
- First posted
- May 27, 2022
- Last posted
- May 27, 2022
- Enrollment
- 36
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- National Cancer Center, JapanLead sponsor
- BayerCollaborator
- National Cancer Center, JapanOverall official - principal investigator
- National Cancer Center, JapanReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.